Composition and kit for detecting Elizabeth pathogens and application of composition and kit
Through multiple fluorescence PCR analysis methods and specific probe compositions, the difficulty of diagnosis of Elizabethan pathogens was solved, and the rapid and accurate detection of Elizabethan meningeal septic, Elizabethan mili and Elizabethan anophelesum was achieved, and the treatment was improved Efficiency and diagnostic accuracy.
Patent Information
- Application Number
- CN202411228014.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-03
- Publication Date
- 2024-11-08
AI Technical Summary
Early diagnosis of Elizabethan pathogens is difficult, and the existing detection methods cannot effectively distinguish between Elizabethan meningeal septic, Elizabethan mili and Elizabethan anopheles, resulting in difficulty in misdiagnosis and treatment, and the culture conditions are harsh, the positive rate is low, and multiple mixed infection cultures are cultured difficulty.
Multiple fluorescence PCR analysis method is used to detect targets on different pathogens, and upstream primers and downstream primers and probes for detecting meningeal Elizabethanum, Elizabethanum Mill and Elizabethanum Anophelesum, achieving simultaneous detection in a single-tube reaction system. and distinguish, combining internal standards to improve detection sensitivity and specificity.
It realizes rapid and accurate detection of Elizabethan pathogens, improves diagnostic efficiency, provides targeted treatment strategies, with a sensitivity of 400 copies/mL, with good specificity, and reduces diagnosis time and mortality.
Smart Images

Figure CN118910299A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of molecular biological detection, and specifically, relates to the detection of Elizabethella pathogens, and more specifically, to the detection of Elizabethella meningoseptica, Elizabethella miltii, and Elizabethella anopheles in the Elizabethella genus. Background Art
[0002] Elizabethkingia spp. belongs to the Flavobacteriaceae family, including Elizabethkingia meningiseptica, Elizabethkingia miller, Elizabethkingia anopheles, E.bruuniana, E.ursingii and E.occulta. Elizabethkingia is an emerging pathogen in human clinical practice. This genus is widely found in the natural environment, such as soil, fresh water and reservoirs. It can cause neonatal meningitis and adult sepsis, pneumonia, eye infection, etc. Adult infection is more common in the frail elderly, immunocompromised, patients who have undergone various invasive diagnostic and treatment procedures or have low immune function. Although it is a rare bacterium in clinical practice, Elizabethkingia infection is on the rise and there have been reports of outbreaks, which need to be taken seriously. Elizabethkingia infection often causes symptoms such as irritability, malnutrition, epilepsy, cerebrospinal fluid, cataracts, etc. Misdiagnosis and lack of effective treatment options make patients almost incurable and ultimately lead to death.
[0003] Elizabethkingia meningoseptica (EM), also known as meningoseptic Flavobacterium, is a non-fermenting Gram-negative bacillus that is widely found in water, soil, chlorine-treated urban water supply systems, medical equipment, etc. It is a conditional pathogen that can often cause infection when the body's immunity is reduced. EM infection sites are diverse, including lung infection, bloodstream infection, central nervous system infection, urinary system infection, etc. EM infection can cause neonatal meningitis, sepsis, pneumonia and other diseases. Common symptoms of infection include fever, cough, dyspnea, headache, impaired consciousness, etc. In recent years, the infection rate of EM has been on the rise, becoming one of the important pathogens of hospital infection. Studies have shown that the mortality rate of patients with EM infection can reach 23.4% within 2 weeks.
[0004] Elizabethkingia miricola is a clinically emerging conditional pathogen that can cause bacteremia and urinary tract infection in newborns and immunocompromised people. In recent years, Elizabethkingia miricola has been reported to cause symptoms such as head tilt, cataracts, and internal bleeding in frogs, causing huge economic losses to my country's frog breeding industry. At the same time, as a potential zoonosis, the bacterium poses a potential threat to human health.
[0005] Elizabethkingia anophelis is an aerobic, non-motile, oxidase-positive, indole-positive, non-fermenting Gram-negative bacillus that is widely distributed in various natural environments, including water, soil, sediment, plants, and the digestive tract of animals. Elizabethkingia anophelis is a relatively newly discovered pathogen, and neonates, postoperative patients, or elderly people with underlying diseases are susceptible to it. Conventional identification methods or biochemical detection methods often fail to distinguish them from other bacteria, and Elizabethkingia anophelis is often mistakenly identified as Elizabethkingia meningoseptica in clinical practice.
[0006] Elizabethella causes similar symptoms and is life-threatening, so early diagnosis of pathogens and timely and effective anti-infection treatment are the key to improving prognosis and can greatly reduce morbidity and mortality. However, it is difficult to identify the type of pathogen infected by clinical symptoms and routine laboratory tests, and the current pathogen culture conditions are relatively harsh, resulting in a low culture positive rate, and the culture of multiple mixed infections is extremely difficult, which brings great trouble to infected patients and clinicians.
[0007] Therefore, there is a need in the art for a product that can simply and quickly detect the above pathogens so as to provide targeted treatment strategies with high sensitivity and good specificity. Summary of the invention
[0008] In view of this, in a first aspect, the present invention provides a composition for detecting Elizabethella pathogens, comprising:
[0009] Upstream primers, downstream primers and probes for detecting Elizabethella meningoseptica as shown in SEQ ID NOs: 1 to 3;
[0010] Upstream primers, downstream primers and probes for detecting Elizabethella miltiorrhiza as shown in SEQ ID NOs: 4 to 6; and
[0011] The upstream primers, downstream primers and probe for detecting Anopheles elizabethii are shown in SEQ ID NOs: 7 to 9.
[0012] The combined detection composition provided by the present invention mainly utilizes a multiplex fluorescent PCR analysis method to detect different pathogens by detecting targets on different pathogens, thereby simultaneously realizing the detection and differentiation of Elizabethella meningoseptica, Elizabethella miler, and Elizabethella anopheles in a single-tube reaction system, so as to provide a targeted strategy for subsequent treatment. The composition of the present invention has a higher detection sensitivity of 400 copies / mL, good specificity, and more accurate detection, providing clinicians with a more sufficient basis for rapid diagnosis and exclusion of different pathogen infections, shortening the time for clinicians to diagnose patients' conditions, and accelerating the implementation of treatment measures for patients.
[0013] Furthermore, the composition also includes upstream primers, downstream primers and probes for detecting Elizabethella as shown in SEQ ID NOs: 10 to 12.
[0014] By further introducing the above-mentioned composition components, it is possible to further detect pathogens of the genus Elizabethella on the basis of the detection and differentiation of Elizabethella meningis, Elizabethella miltii and Elizabethella anopheles, and further differentiate Elizabethella from other pathogens.
[0015] Furthermore, the composition includes an upstream primer, a downstream primer and a probe for detecting an internal standard.
[0016] In some specific embodiments, the internal standard is a human internal standard gene. In a specific embodiment, the internal standard is RNase P.
[0017] Furthermore, the composition includes upstream primers, downstream primers and probes for detecting internal standards as shown in SEQ ID NOs: 13 to 15.
[0018] Furthermore, the fluorescent groups of the probes of the composition of the present invention are different from each other and do not interfere with each other.
[0019] In this article, "different from each other and not interfering with each other" means that the fluorescent groups used in each probe in the composition are different and will not affect each other's detection, that is, different channels can be used for detection. For example, ATTO425, Quasar705, FAM, HEX, ROX and CY5 can be used. The absorbance values of these groups are not close, and different channels can be selected, so they will not interfere with each other.
[0020] In some specific embodiments, the fluorescent reporter group of the Elizabethella meningoseptica probe is FAM; the fluorescent reporter group of the Elizabethella mier probe is HEX (or VIC); the fluorescent reporter group of the Anopheles Elizabethella probe is ROX; the fluorescent reporter group of the Elizabethella probe is Quasar705; and the fluorescent reporter group of the internal standard probe is CY5.
[0021] Further, in some embodiments, the composition of the present invention may include one or more pairs of the above primer and probe pairs. In the present invention, "pair" refers to upstream and downstream primers and probes that match each other for detecting a target.
[0022] The composition of the present invention can be combined into any combination of detection corresponding to 5 targets. Those skilled in the art can combine as needed to detect which targets, that is, to combine the primers and probe pairs corresponding to the targets. These combinations are all included in the present invention.
[0023] For example, it may include any 4 pairs of the above 5 pairs of primers and probes, any 3 pairs of the above 5 pairs of primers and probes, any 2 pairs of the above 5 pairs of primers and probes, or any 1 pair of the above 5 pairs of primers and probes.
[0024] In some specific embodiments, the compositions of the present invention are used for fluorescent PCR.
[0025] Furthermore, the 3' end of the probe also has a non-fluorescent quencher.
[0026] Furthermore, the 3' end of the probe also has a quencher group, such as BHQ1 or BHQ2.
[0027] In a specific embodiment, the 3' end of the probe is BHQ1.
[0028] In a specific embodiment, each component of the composition of the present invention is present in a separate package.
[0029] In a particular embodiment, the components of the composition of the present invention are present in the same package.
[0030] Furthermore, the components of the composition of the present invention are present in a mixed form.
[0031] In a second aspect, the present invention provides the use of the above-mentioned composition of the present invention in the preparation of a kit for detecting Elizabethella pathogens, wherein the pathogen is one or more of Elizabethella, Elizabethella meningoseptica, Elizabethella miltii, or Elizabethella anopheles.
[0032] In a third aspect, the present invention provides a kit for detecting Elizabethella pathogens, wherein the kit comprises the composition of the present invention as described above.
[0033] Furthermore, the kit also includes a negative quality control product and a positive quality control product.
[0034] In a specific embodiment, the negative control is at least one of DEPC H2O and physiological saline. The positive control is at least one of a fragment plasmid or a positive strain of Elizabethella, Elizabethella meningoseptica, Elizabethella miltii, and Elizabethella anopheles.
[0035] Furthermore, the kit also includes dNTP, PCR buffer and Mg 2+ At least one of .
[0036] Furthermore, the kit also includes: at least one of a nucleic acid releasing reagent, a nucleic acid extracting reagent, and a DNA polymerase.
[0037] Furthermore, the kit also includes a nucleic acid release reagent, a nucleic acid extraction reagent, dNTP, dUTP, uracil glycosylase (UDG), DNA polymerase, PCR buffer and Mg 2+ At least one of .
[0038] Furthermore, the concentration of the DNA polymerase is 5 U / reaction to 15 U / reaction, for example, the DNA polymerase may be Taq enzyme.
[0039] In a specific embodiment, the kit of the present invention comprises Taq enzyme, UDG enzyme, Mg 2+ , dNTP(U)s, primers, probes and PCR buffer.
[0040] The main components of PCR buffer include Tris-HCl, MgCl2, KCl, and Triton X-100. The total volume in a single PCR reaction tube is generally 20 μl to 200 μl.
[0041] In a specific embodiment, the kit of the present invention is compatible with a digital PCR amplification system, that is, it can be directly used for amplification on a digital PCR instrument.
[0042] In a fourth aspect, a method for detecting Elizabethella pathogens for non-diagnostic purposes is provided, the method comprising the following steps:
[0043] 1) Extracting nucleic acid from the sample to be tested;
[0044] 2) using the composition of the present invention or the kit of the present invention as described above to perform fluorescent quantitative PCR on the nucleic acid obtained in step 1);
[0045] 3) Obtain and analyze the results.
[0046] In the present invention, the sample used for detection may be blood, etc., but is not limited thereto.
[0047] Furthermore, the reaction conditions of the fluorescent quantitative PCR are:
[0048] UDG enzyme reaction, temperature is 50-60℃, time is 1-6min, 1 cycle; pre-denaturation, temperature is 90-95℃, time is 1-6min, 1 cycle; denaturation, temperature is 90-95℃, time is 5-20 seconds, annealing, temperature is 55℃-60℃, time is 10-60 seconds, 30-50 cycles, and fluorescence is collected.
[0049] In a specific embodiment, a composition is provided for preparing a reagent for detecting Elizabethella pathogens, wherein the detection comprises the following steps:
[0050] 1) Extracting nucleic acid from the sample to be tested;
[0051] 2) using the composition of the present invention or the kit of the present invention as described above to perform fluorescent quantitative PCR on the nucleic acid obtained in step 1);
[0052] 3) Obtain and analyze the results.
[0053] Furthermore, the reaction conditions of the fluorescent quantitative PCR are:
[0054] UDG enzyme reaction, temperature is 50-60℃, time is 1-6min, 1 cycle; pre-denaturation, temperature is 90-95℃, time is 1-6min, 1 cycle; denaturation, temperature is 90-95℃, time is 5-20 seconds, annealing, temperature is 55℃-60℃, time is 10-60 seconds, 30-50 cycles, and fluorescence is collected.
[0055] Herein, the term "non-diagnostic purpose" means that it is not intended to obtain information on whether an individual is infected with the above pathogens and suffers from the infection. For example, the method can be used to detect whether the above pathogens are present in a culture (such as blood, etc.). BRIEF DESCRIPTION OF THE DRAWINGS
[0056] Figure 1 This is a graph showing the test results of the composition of the present invention (Elizabethia meningiseptica, Elizabethia miltii, and Elizabethia anopheles);
[0057] Figure 2 This is a graph showing the test results of the composition of the present invention (Elizabethella meningoseptica, Elizabethella miltii, Elizabethella anopheles, Elizabethella spp.);
[0058] Figures 3 to 6 is a sensitivity result diagram of the composition of the present invention (Elizabethella meningoseptica, Elizabethella miltii, Elizabethella anopheles, and Elizabethella spp.);
[0059] Figure 7 It is a specific result diagram of the composition of the present invention;
[0060] Figures 8 to 11 This is a graph of the precision results of the composition of the present invention (Elizabethella meningoseptica, Elizabethella miltii, Elizabethella anopheles, and Elizabethella spp.);
[0061] Fig.12 This is a graph showing the test results of the comparative example composition of the present invention. DETAILED DESCRIPTION
[0062] The present invention will be described in detail below in conjunction with specific embodiments and examples, and the advantages and various effects of the present invention will be more clearly presented. It should be understood by those skilled in the art that these specific embodiments and examples are used to illustrate the present invention, rather than to limit the present invention.
[0063] Example 1: Primers and probes used in the present invention
[0064] The primers and probes used in the present invention are shown in Table 1 below:
[0065] Table 1
[0066]
[0067] Among them, the fluorescent reporter group of the Elizabethella meningoseptica probe is FAM; the fluorescent reporter group of the Elizabethella miltii probe is HEX (VIC); the fluorescent reporter group of the Anopheles Elizabethella is ROX; the fluorescent reporter group of the Elizabethella probe is Quasar705; and the fluorescent reporter group of the internal standard is CY5.
[0068] Example 2: Method for detecting pathogens
[0069] Reagent preparation:
[0070] According to the number of samples to be tested, positive controls, and negative controls, take the corresponding amount of PCR reaction solution and enzyme in proportion, mix them thoroughly to form a PCR system, centrifuge at 2000 rpm for 10 seconds and set aside. The real-time fluorescence PCR reaction system is configured according to the following Table 2.
[0071] Table 2
[0072]
[0073]
[0074] Sample handling and loading:
[0075] Take 300 μL of the sample to be tested, negative control, and positive control into a 1.5 mL centrifuge tube, and use the nucleic acid extraction or purification reagent of Shengxiang Biotechnology Co., Ltd. to extract nucleic acid according to its instructions; take 10 μL of the above-treated samples, negative controls, and positive controls and add them to the corresponding 0.2 mL PCR reaction tubes, add 40 μL of PCR mixture to each tube, and cover the tube.
[0076] PCR amplification:
[0077] PCR amplification was performed on a SLAN-96P real-time fluorescence quantitative PCR instrument according to the temperature and time settings shown in Table 3.
[0078] Table 3
[0079]
[0080] Result analysis and judgment
[0081] After the reaction is completed, the results are automatically saved, and the amplification curves of the detection targets are analyzed separately. According to the analyzed image, adjust the Start value, End value, and Threshold value of the Baseline (users can adjust according to actual conditions, the Start value can be set between 3 and 15, and the End value can be set between 5 and 20, and adjust the amplification curve of the negative control to make it flat or below the threshold line), click Analyze to analyze, so that each parameter meets the requirements of the following "Quality Control", and then record the qualitative results in the Plate window.
[0082] Quality Control:
[0083] Negative control: FAM, HEX, ROX, Quasar705 and CY5 channel Ct>40 or no Ct value (NoCt);
[0084] Positive control: FAM, HEX, ROX, Quasar705 and CY5 channels all had Ct≤35;
[0085] The above requirements must be met simultaneously in the same experiment, otherwise, the experiment will be invalid and must be repeated.
[0086] Through the study of reference values, it was determined that the Ct reference value of the target gene detected by this kit is 40, and the reference value of the internal standard Ct is 40.
[0087] The samples to be tested are judged according to the following table 4:
[0088] If the detection target Ct is ≤40, it is judged as positive; if the detection target Ct is greater than 40 or there is no amplification curve (NoCt), it is judged as negative.
[0089] Table 4
[0090]
[0091] Example 3: Test results of the test samples of the composition of the present invention
[0092] The primers and probes shown in Example 1 were used according to the method of Example 2 to perform PCR detection on a SLAN-96P real-time fluorescence quantitative PCR instrument for a mixed sample of Elizabethella meningiseptica, Elizabethella milt, and Elizabethella anopheles, as well as a mixed sample of Elizabethella meningiseptica, Elizabethella milt, Elizabethella anopheles, and Elizabethella spp. The detection results are shown in Figures 1-2As shown in the figure, it can be seen that the composition of the present invention can perform good detection on various pathogen combinations.
[0093] Example 4: Sensitivity of the composition of the present invention
[0094] The composition of Example 1 of the present invention was used to perform LOD (sensitivity) detection on each target at concentrations of 1000, 800, and 400 copies / mL, respectively, to simulate clinical samples, and 20 multiplex PCR tests were performed on a SLAN-96P real-time fluorescence quantitative PCR instrument. The results are shown in FIG. Figures 3 to 6 As shown, it is shown that each channel can still accurately detect samples as low as 400 copies / mL, with a detection rate of 100%, indicating that the sensitivity of the composition of the present invention is 400 copies / mL.
[0095] Example 5. Specificity of the composition of the present invention
[0096] The composition of the present invention has no cross reaction with other pathogens similar to Elizabethella pathogens (Candida glabrata, Streptococcus pneumoniae, Serratia marcescens, Escherichia coli, Staphylococcus epidermidis, Acinetobacter baumannii, Klebsiella pneumoniae, Candida tropicalis, Candida krusei, Enterococcus faecalis, Haemophilus influenzae, Staphylococcus aureus, Butyric acid bacteria, Enterobacter cloacae, Pseudomonas aeruginosa, Legionella pneumophila, Clostridium botulinum, Micrococcus luteus, Rhodococcus equi, Listeria monocytogenes, Acinetobacter junii, Haemophilus parainfluenzae, influenza A virus, influenza B virus, Neisseria meningitidis). The results are as follows Figure 7 As shown, it is shown that the composition of the present invention has good specificity.
[0097] Example 6: Precision of the composition of the present invention
[0098] In this example, the positive samples were diluted to a medium concentration level for precision determination, and each sample was measured 10 times. Figure 8-11 As shown, the detection rates of these samples were all 100%, and the coefficient of variation (CV) of the Ct value was less than 5%. It can be considered that this kit has good detection precision both within and between batches.
[0099] Comparative Example 1: Other primers and probes designed by the present invention that have poor effects
[0100] Due to the principle of complementary base pairing, dimers will form between primers and (or) probes, but this probability is very small and can be ruled out at the beginning of the design. However, when multiple pathogens are detected together, there are many primers and probes, and dimers are likely to occur between primers and primers, probes and probes, or primers and probes. In order to ensure the conservatism of the design (conservatism is crucial to the accuracy of the detection), and to consider the mutual interference between different primers and probes, the primers and probes need to be carefully designed.
[0101] Therefore, the inventors also designed some other primers and probes to form different detection systems (sequences not shown), which are also used to detect the above pathogens. Fig.12 As shown in the figure, it can be seen that the detected Ct value is delayed and the fluorescence increment is significantly decreased, which further illustrates the superiority of the composition of the present invention.
Claims
1. A composition for detecting Elizabethella pathogens, comprising: Upstream primers, downstream primers and probes for detecting Elizabethella meningoseptica as shown in SEQ ID NOs: 1 to 3; Upstream primers, downstream primers and probes for detecting Elizabethella miltiorrhiza as shown in SEQ ID NOs: 4 to 6; and The upstream primers, downstream primers and probe for detecting Anopheles elizabethii are shown in SEQ ID NOs: 7 to 9.
2. The composition according to claim 1, characterized in that The composition also includes upstream primers, downstream primers and probes for detecting Elizabethella as shown in SEQ ID NOs: 10 to 12.
3. The composition according to claim 2, characterized in that The composition also includes an upstream primer, a downstream primer and a probe for detecting an internal standard.
4. The composition according to claim 3, characterized in that The fluorescent reporter group of Elizabethella meningoseptica is FAM; the fluorescent reporter group of Elizabethella milt is HEX or VIC; the fluorescent reporter group of Elizabethella anopheles is ROX; the fluorescent reporter group of the Elizabethella probe is Quasar705; and the fluorescent reporter group of the internal standard probe is CY5.
5. The composition according to any one of claims 1 to 4, characterized in that The components of the composition are present in admixture.
6. Use of the composition according to any one of claims 1 to 5 in preparing a kit for detecting Elizabethella pathogens, wherein The pathogen is one or more of Elizabethella, Elizabethella meningoseptica, Elizabethella miltii, or Elizabethella anopheles.
7. A kit for detecting Elizabethella pathogens, the kit comprising the composition according to any one of claims 1 to 5.
8. The kit according to claim 7, characterized in that The kit also includes a negative quality control product and a positive quality control product.
9. The kit according to claim 7 or 8, characterized in that The kit also includes: a nucleic acid release reagent, a nucleic acid extraction reagent, a DNA polymerase, dNTP, an UDG enzyme, a PCR buffer, and Mg 2+ At least one of .
10. Use of a composition for preparing a reagent for detecting Elizabethella pathogens, the detection comprising the following steps: 1) Extracting nucleic acid from the sample to be tested; 2) performing fluorescent quantitative PCR on the nucleic acid obtained in step 1) using the composition according to any one of claims 1 to 5 or the kit according to any one of claims 7 to 9; 3) Obtain and analyze the results.
